OBJECTIVE: Recent data suggest that vagus nerve stimulation (VNS) can inhibit cytokine release by inflammatory cells. Accordingly, an association between impaired cardiac parasympathetic function, as assessed by heart rate variability (HRV), and increased markers of inflammation has recently been reported. In this study we assessed the effect of direct left VNS on inflammatory markers and HRV in patients with refractory epilepsy. METHODS: A 24-hour electrocardiogram Holter recording was performed both at baseline and after 3 months of left VNS in 8 patients (age 32 +/- 24 years, 2 men) who underwent implantation of a VNS device because of refractory epilepsy. Tumor necrosis factor-alpha, interleukin-6 and C-reactive protein serum levels were measured, as markers of inflammation, at the same times. RESULTS: No significant changes were found after 3 months of left VNS, compared to baseline, both for HRV variables and inflammatory markers. Also, no consistent correlation could be demonstrated between HRV parameters and inflammatory markers in these patients. CONCLUSIONS: Our data in epileptic patients without cardiovascular disease failed to show a significant effect of left VNS on cardiac autonomic function and on systemic inflammation at short-term follow-up. (c) 2008 S. Karger AG, Basel.
OBJECTIVE: Recent data suggest that vagus nerve stimulation (VNS) can inhibit cytokine release by inflammatory cells. Accordingly, an association between impaired cardiac parasympathetic function, as assessed by heart rate variability (HRV), and increased markers of inflammation has recently been reported. In this study we assessed the effect of direct left VNS on inflammatory markers and HRV in patients with refractory epilepsy. METHODS: A 24-hour electrocardiogram Holter recording was performed both at baseline and after 3 months of left VNS in 8 patients (age 32 +/- 24 years, 2 men) who underwent implantation of a VNS device because of refractory epilepsy. Tumor necrosis factor-alpha, interleukin-6 and C-reactive protein serum levels were measured, as markers of inflammation, at the same times. RESULTS: No significant changes were found after 3 months of left VNS, compared to baseline, both for HRV variables and inflammatory markers. Also, no consistent correlation could be demonstrated between HRV parameters and inflammatory markers in these patients. CONCLUSIONS: Our data in epilepticpatients without cardiovascular disease failed to show a significant effect of left VNS on cardiac autonomic function and on systemic inflammation at short-term follow-up. (c) 2008 S. Karger AG, Basel.
Authors: Harwood Kwan; Luca Garzoni; Hai Lun Liu; Mingju Cao; Andre Desrochers; Gilles Fecteau; Patrick Burns; Martin G Frasch Journal: Bioelectron Med Date: 2016-09-14
Authors: André Diedrich; Vasile Urechie; Dana Shiffer; Stefano Rigo; Maura Minonzio; Beatrice Cairo; Emily C Smith; Luis E Okamoto; Franca Barbic; Andrea Bisoglio; Alberto Porta; Italo Biaggioni; Raffaello Furlan Journal: Auton Neurosci Date: 2021-09-29 Impact factor: 3.145
Authors: Helena Dolphin; Tim Dukelow; Ciaran Finucane; Sean Commins; Paul McElwaine; Sean P Kennelly Journal: Front Neurosci Date: 2022-06-16 Impact factor: 5.152
Authors: Andreas D Niederbichler; Stephan Papst; Leif Claassen; Andreas Jokuszies; Kyros Ipaktchi; Kerstin Reimers; Tobias Hirsch; Lars Steinstraesser; Theresia Kraft; Peter M Vogt Journal: Eplasty Date: 2010-06-21
Authors: Matthijs Kox; Lucas T van Eijk; Tim Verhaak; Tim Frenzel; Harmke D Kiers; Jelle Gerretsen; Johannes G van der Hoeven; Lilian Kornet; Avram Scheiner; Peter Pickkers Journal: Arthritis Res Ther Date: 2015-06-07 Impact factor: 5.156
Authors: Ivan Emmanuel Ramos-Martínez; María Carmen Rodríguez; Marco Cerbón; Juan Carlos Ramos-Martínez; Edgar Gustavo Ramos-Martínez Journal: Int J Mol Sci Date: 2021-12-14 Impact factor: 5.923